IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
Abstract Patients undergoing heart transplantation (HTx) with active infection of left ventricular assist devices (LVAD) are at high risk for postoperative infections. Between 2021 and 2022, five (P1–P5) of a total of n = 44 patients underwent HTx in our department while suffering from LVAD infectio...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2022-10-01
|
| シリーズ: | ESC Heart Failure |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1002/ehf2.14074 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
